Walgreens Ice Blue Pain Relieving

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be cleaned prior to the application of the product. For adults and children aged 2 years and older, the product may be applied to the affected area up to 3 to 4 times daily. It is important to note that the product is not recommended for use in children under 2 years of age; consultation with a healthcare professional is advised in such cases.

Contraindications

The product is contraindicated in the following situations:

• Concurrent use with other topical pain relievers is not recommended due to the potential for increased irritation or adverse effects.

• Application alongside heating pads or other heating devices is contraindicated, as this may enhance absorption and lead to increased risk of systemic effects.

• Contact with the eyes must be avoided to prevent irritation or injury.

• Tight bandaging of the application site is contraindicated, as it may restrict circulation and exacerbate local reactions.

• Application to wounds or damaged skin is not advised, as this may increase the risk of systemic absorption and local irritation.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid using this product in conjunction with other topical pain relievers, as this may increase the risk of adverse effects. Additionally, the use of heating pads or other heating devices while using this product is contraindicated, as it may exacerbate skin irritation or lead to burns.

Patients should be cautioned to avoid contact with the eyes, as this may result in significant irritation. It is also important to instruct patients not to bandage the area tightly after application, as this could impede circulation and lead to further complications. The product should not be applied to wounds or damaged skin to prevent potential adverse reactions.

Patients are advised to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222.

General precautions include advising pregnant or breastfeeding individuals to consult a healthcare professional prior to use. It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse.

Side Effects

Patients using this product should be aware that it is for external use only. It is important to avoid using this product in conjunction with other topical pain relievers or heating devices, such as heating pads. Contact with the eyes should be strictly avoided, and the product should not be applied to wounds or damaged skin. Additionally, patients should refrain from bandaging the area tightly after application.

In the event that the condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients are advised to stop use and consult a healthcare professional.

For pregnant or breastfeeding individuals, it is recommended to seek advice from a health professional prior to use.

This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact should be made with a Poison Control Center at 1-800-222-1222.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreens Ice Blue Pain Relieving (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this medication; consultation with a healthcare professional is advised. For adults and children aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers should consider individual circumstances and the specific needs of the patient when making recommendations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the prescribing information regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be informed to stop using the product and consult a doctor if their condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then occur again within a few days.

When using this product, healthcare providers should emphasize the following precautions to patients:

• Patients should not use this product in conjunction with other topical pain relievers.

• Advise patients against using heating pads or other heating devices while using this product.

• Patients should avoid contact with the eyes to prevent irritation.

• It is important to instruct patients not to bandage the area tightly after application.

• Patients should also be cautioned not to apply the product to wounds or damaged skin to avoid adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed when not in use to maintain its integrity. It should be stored at room temperature, ensuring that it is not exposed to freezing conditions. Additionally, it is crucial to avoid placing the product near heat sources or open flames, as this could compromise its safety and effectiveness.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being 3 to 4 times daily to the affected area. For children under 2 years of age, it is advised to consult a doctor before use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Walgreens Ice Blue Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)